# Sirolimus to Treat Diabetic Macular Edema

> **NCT00711490** · PHASE1,PHASE2 · COMPLETED · sponsor: **National Eye Institute (NEI)** · enrollment: 5 (actual)

## Conditions studied

- Diabetic Retinopathy

## Interventions

- **DRUG:** Sirolimus

## Key facts

- **NCT ID:** NCT00711490
- **Lead sponsor:** National Eye Institute (NEI)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2024-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00711490

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00711490, "Sirolimus to Treat Diabetic Macular Edema". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00711490. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*